Skip to main content
Top
Published in: Endocrine 1/2018

01-10-2018 | Letter to the Editor

Statins as potential agents for the prevention and treatment of osteoporosis

Authors: F Kaleağasıoğlu, E Olcay, R Onur

Published in: Endocrine | Issue 1/2018

Login to get access

Excerpt

We read with interest the article entitled “Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats” which was recently published by Shahrezaee and co-workers [1]. In this study, oral treatment with simvastatin (25 mg/kg/day), and lovastatin (20 mg/kg/ day) for 60 days significantly increased serum calcium level, expression of osteogenic genes, trabecular bone mineral density (BMD), the bone volume/total volume, and bone thickness in ovariectomized (OVX) rats. Both biomechanical parameters, ultimate load and stiffness, in femur and vertebra were significantly improved only by simvastatin versus the OVX group. …
Literature
1.
go back to reference M. Shahrezaee, A. Oryan, F. Bastami, S. Hosseinpour, M.H. Shahrezaee, A. Kamali, Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats. Endocrine 60(1), 138–150 (2018)CrossRefPubMed M. Shahrezaee, A. Oryan, F. Bastami, S. Hosseinpour, M.H. Shahrezaee, A. Kamali, Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats. Endocrine 60(1), 138–150 (2018)CrossRefPubMed
2.
go back to reference F. Kaleağasıoğlu, E. Olcay, V. Olgaç, Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin. Knee. Surg. Sports Traumatol. Arthrosc. 25(6), 1884–1891 (2017)CrossRefPubMed F. Kaleağasıoğlu, E. Olcay, V. Olgaç, Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin. Knee. Surg. Sports Traumatol. Arthrosc. 25(6), 1884–1891 (2017)CrossRefPubMed
3.
go back to reference T.K. Lin, P. Chou, C.H. Lin, Y.J. Hung, G.P. Jong, Long-term effect of statins on the risk of new-onset osteoporosis: a nationwide population-based cohort study. PLoS One 13(5), e0196713 (2018)CrossRefPubMedPubMedCentral T.K. Lin, P. Chou, C.H. Lin, Y.J. Hung, G.P. Jong, Long-term effect of statins on the risk of new-onset osteoporosis: a nationwide population-based cohort study. PLoS One 13(5), e0196713 (2018)CrossRefPubMedPubMedCentral
Metadata
Title
Statins as potential agents for the prevention and treatment of osteoporosis
Authors
F Kaleağasıoğlu
E Olcay
R Onur
Publication date
01-10-2018
Publisher
Springer US
Published in
Endocrine / Issue 1/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1650-0

Other articles of this Issue 1/2018

Endocrine 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.